Inventor
BOSS ANDERS HASAGER
US17 patents
⚠️ This page may combine multiple inventors who share the name “BOSS ANDERS HASAGER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MANNKIND CORP
12 patentsUS7943572B2May 17, 2011
Superior control of blood glucose in diabetes treatment
MANNKIND CORP57 citations92
US11998591B2Jun 4, 2024
Method of treating diabetes type 2 by administering ultrarapid acting insulin
MANNKIND CORP0 citations61
US11931404B2Mar 19, 2024
Use of ultrarapid acting insulin
MANNKIND CORP0 citations61
US11013788B2May 25, 2021
Use of ultrarapid acting insulin
MANNKIND CORP0 citations61
US12303554B2May 20, 2025
Use of ultrarapid acting insulin
MANNKIND CORP0 citations60
US11559569B2Jan 24, 2023
Use of ultrarapid acting insulin
MANNKIND CORP0 citations60
US10857207B2Dec 8, 2020
Method of treating diabetes type 2 by administering ultrarapid acting insulin
MANNKIND CORP0 citations51
US10307464B2Jun 4, 2019
Use of ultrarapid acting insulin
MANNKIND CORP0 citations51
US9943571B2Apr 17, 2018
Use of ultrarapid acting insulin
MANNKIND CORP0 citations51
US9801925B2Oct 31, 2017
Potentiation of glucose elimination
MANNKIND CORP0 citations51
US10772935B2Sep 15, 2020
Use of ultrarapid acting insulin
MANNKIND CORP0 citations50
US10046031B2Aug 14, 2018
Use of ultrarapid acting insulin
MANNKIND CORP0 citations50
BOSS ANDERS HASAGER
3 patentsUS8258095B2Sep 4, 2012
Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content
BOSS ANDERS HASAGER46 citations95
US9597374B2Mar 21, 2017
Use of ultrarapid acting insulin
BOSS ANDERS HASAGER2 citations81
US9006175B2Apr 14, 2015
Potentiation of glucose elimination
BOSS ANDERS HASAGER1 citations61